For example, He et al. discovered that sorafenib-resistant hepatoma cells can upregulate miR-21, which in turn inhibits autophagy induced by sorafenib through downregulation of PTEN and altering the activation sequence of Akt pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.